s6y

CBD Life Sciences Inc.

Ticker
CBDL
CIK
1776073
Industry
Medicinal Chemicals & Botanical Products

Financials 1

  1. 1-K Annual Report Pursuant to Regulation A for period ending Dec 31, 2019

News 4

  1. 1-U Current Report pursuant to Regulation A
  2. 1-Z Exit Report under Regulation A
  3. 1-U Current Report pursuant to Regulation A
  4. 1-Z Exit Report under Regulation A

Prospectus 25

  1. 1-A Offering statement under Regulation A
  2. 1-A POS Post-qualification amendment to a 1-A offering statement
  3. 1-A POS Post-qualification amendment to a 1-A offering statement
  4. 1-A POS Post-qualification amendment to a 1-A offering statement
  5. 1-A POS Post-qualification amendment to a 1-A offering statement
  6. 1-A/A Offering statement under Regulation A
  7. 1-A/A Offering statement under Regulation A
  8. 1-A Offering statement under Regulation A
  9. 1-A Offering statement under Regulation A
  10. 1-A POS Post-qualification amendment to a 1-A offering statement

All 25 prospectus filings

Other 52

  1. QUALIF
  2. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  3. UPLOAD Letter (PDF)
  4. 253G2 Reflects information that constitutes a substantive change from or addition to the information set forth in the last offering circular
  5. QUALIF
  6. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  7. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  8. UPLOAD Letter (PDF)
  9. 253G2 Reflects information that constitutes a substantive change from or addition to the information set forth in the last offering circular
  10. QUALIF

All 52 other filings